Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $56.0 million.

  • Haemonetics' Non-Current Deferred Tax Liability fell 890.47% to $56.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $56.0 million, marking a year-over-year decrease of 890.47%. This contributed to the annual value of $62.6 million for FY2025, which is 5826.41% down from last year.
  • Latest data reveals that Haemonetics reported Non-Current Deferred Tax Liability of $56.0 million as of Q4 2025, which was down 890.47% from $58.2 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Non-Current Deferred Tax Liability ranged from a high of $149.9 million in Q1 2024 and a low of $24.3 million during Q3 2021
  • For the 5-year period, Haemonetics' Non-Current Deferred Tax Liability averaged around $61.1 million, with its median value being $58.8 million (2025).
  • In the last 5 years, Haemonetics' Non-Current Deferred Tax Liability surged by 16657.15% in 2022 and then crashed by 5826.41% in 2025.
  • Haemonetics' Non-Current Deferred Tax Liability (Quarter) stood at $24.6 million in 2021, then soared by 63.39% to $40.2 million in 2022, then soared by 55.03% to $62.2 million in 2023, then decreased by 1.28% to $61.5 million in 2024, then fell by 8.9% to $56.0 million in 2025.
  • Its Non-Current Deferred Tax Liability was $56.0 million in Q4 2025, compared to $58.2 million in Q3 2025 and $59.5 million in Q2 2025.